These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 30158163)

  • 1. Optokinetic nystagmus in patients with SCA: A bedside test for oculomotor dysfunction grading.
    Seshagiri DV; Pal PK; Jain S; Yadav R
    Neurology; 2018 Sep; 91(13):e1255-e1261. PubMed ID: 30158163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Challenges in sleep stage R scoring in patients with autosomal dominant spinocerebellar ataxias (SCA1, SCA2 and SCA3) and oculomotor abnormalities: a whole night polysomnographic evaluation.
    Seshagiri DV; Sasidharan A; Kumar G; Pal PK; Jain S; Kutty BM; Yadav R
    Sleep Med; 2018 Feb; 42():97-102. PubMed ID: 29458753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biological and clinical characteristics of individuals at risk for spinocerebellar ataxia types 1, 2, 3, and 6 in the longitudinal RISCA study: analysis of baseline data.
    Jacobi H; Reetz K; du Montcel ST; Bauer P; Mariotti C; Nanetti L; Rakowicz M; Sulek A; Durr A; Charles P; Filla A; Antenora A; Schöls L; Schicks J; Infante J; Kang JS; Timmann D; Di Fabio R; Masciullo M; Baliko L; Melegh B; Boesch S; Bürk K; Peltz A; Schulz JB; Dufaure-Garé I; Klockgether T
    Lancet Neurol; 2013 Jul; 12(7):650-8. PubMed ID: 23707147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autosomal dominant cerebellar ataxia type I: oculomotor abnormalities in families with SCA1, SCA2, and SCA3.
    Bürk K; Fetter M; Abele M; Laccone F; Brice A; Dichgans J; Klockgether T
    J Neurol; 1999 Sep; 246(9):789-97. PubMed ID: 10525976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conversion of individuals at risk for spinocerebellar ataxia types 1, 2, 3, and 6 to manifest ataxia (RISCA): a longitudinal cohort study.
    Jacobi H; du Montcel ST; Romanzetti S; Harmuth F; Mariotti C; Nanetti L; Rakowicz M; Makowicz G; Durr A; Monin ML; Filla A; Roca A; Schöls L; Hengel H; Infante J; Kang JS; Timmann D; Casali C; Masciullo M; Baliko L; Melegh B; Nachbauer W; Bürk-Gergs K; Schulz JB; Riess O; Reetz K; Klockgether T
    Lancet Neurol; 2020 Sep; 19(9):738-747. PubMed ID: 32822634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequency of SCA1, SCA2, SCA3/MJD, SCA6, SCA7, and DRPLA CAG trinucleotide repeat expansion in patients with hereditary spinocerebellar ataxia from Chinese kindreds.
    Tang B; Liu C; Shen L; Dai H; Pan Q; Jing L; Ouyang S; Xia J
    Arch Neurol; 2000 Apr; 57(4):540-4. PubMed ID: 10768629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Electrophysiological evaluation of spinocerebellar ataxias 1, 2 and 3.
    Yadav R; Pal PK; Krishna N; Amar BR; Jain S; Purushottam M
    J Neurol Sci; 2012 Jan; 312(1-2):142-5. PubMed ID: 21880333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Eye Movement Abnormalities Are Ubiquitous in the Spinocerebellar Ataxias.
    Stephen CD; Schmahmann JD
    Cerebellum; 2019 Dec; 18(6):1130-1136. PubMed ID: 31175630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heterogeneous nonataxic phenotypes of spinocerebellar ataxia in a Taiwanese population.
    Chen SJ; Lee NC; Chien YH; Hwu WL; Lin CH
    Brain Behav; 2019 Oct; 9(10):e01414. PubMed ID: 31523939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term disease progression in spinocerebellar ataxia types 1, 2, 3, and 6: a longitudinal cohort study.
    Jacobi H; du Montcel ST; Bauer P; Giunti P; Cook A; Labrum R; Parkinson MH; Durr A; Brice A; Charles P; Marelli C; Mariotti C; Nanetti L; Panzeri M; Rakowicz M; Sulek A; Sobanska A; Schmitz-Hübsch T; Schöls L; Hengel H; Baliko L; Melegh B; Filla A; Antenora A; Infante J; Berciano J; van de Warrenburg BP; Timmann D; Szymanski S; Boesch S; Kang JS; Pandolfo M; Schulz JB; Molho S; Diallo A; Klockgether T
    Lancet Neurol; 2015 Nov; 14(11):1101-8. PubMed ID: 26377379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequency analysis and clinical characterization of spinocerebellar ataxia types 1, 2, 3, 6, and 7 in Korean patients.
    Lee WY; Jin DK; Oh MR; Lee JE; Song SM; Lee EA; Kim GM; Chung JS; Lee KH
    Arch Neurol; 2003 Jun; 60(6):858-63. PubMed ID: 12810491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Spinocerebellar ataxias type 1 and 2: comparison of clinical, electrophysiological and magnetic resonance evaluation].
    Rakowicz M; Zdzienicka E; Poniatowska R; Waliniowska E; Sułek A; Jakubowska T; Niedzielska K; Rola R; Wierzbicka A; Hoffman-Zacharska D; Głazowski C; Jakubczyk T; Niewiadomska M; Zaremba J
    Neurol Neurochir Pol; 2005; 39(4):263-275. PubMed ID: 16096942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abnormal eye movements in spinocerebellar ataxia type 3.
    Lin J; Zhang L; Cao B; Wei Q; Ou R; Hou Y; Xu X; Liu K; Gu X; Shang H
    BMC Neurol; 2021 Jan; 21(1):28. PubMed ID: 33468086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical value of vestibulo-ocular reflex in the differentiation of spinocerebellar ataxias.
    Kim JM; Nam TS; Choi SM; Kim BC; Lee SH
    Sci Rep; 2023 Sep; 13(1):14783. PubMed ID: 37679515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spinocerebellar ataxias types 1, 2 and 3: age adjusted clinical severity of disease at presentation correlates with size of CAG repeat lengths.
    Netravathi M; Pal PK; Purushottam M; Thennarasu K; Mukherjee M; Jain S
    J Neurol Sci; 2009 Feb; 277(1-2):83-6. PubMed ID: 19049837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spinocerebellar ataxia types 1, 2, 3, and 6: disease severity and nonataxia symptoms.
    Schmitz-Hübsch T; Coudert M; Bauer P; Giunti P; Globas C; Baliko L; Filla A; Mariotti C; Rakowicz M; Charles P; Ribai P; Szymanski S; Infante J; van de Warrenburg BP; Dürr A; Timmann D; Boesch S; Fancellu R; Rola R; Depondt C; Schöls L; Zdienicka E; Kang JS; Döhlinger S; Kremer B; Stephenson DA; Melegh B; Pandolfo M; di Donato S; du Montcel ST; Klockgether T
    Neurology; 2008 Sep; 71(13):982-9. PubMed ID: 18685131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alterations in cortical excitability and central motor conduction time in spinocerebellar ataxias 1, 2 and 3: a comparative study.
    Jhunjhunwala K; Prashanth DK; Netravathi M; Jain S; Purushottam M; Pal PK
    Parkinsonism Relat Disord; 2013 Mar; 19(3):306-11. PubMed ID: 23219306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spinocerebellar ataxia types 1, 2, 3 and 6: the clinical spectrum of ataxia and morphometric brainstem and cerebellar findings.
    Jacobi H; Hauser TK; Giunti P; Globas C; Bauer P; Schmitz-Hübsch T; Baliko L; Filla A; Mariotti C; Rakowicz M; Charles P; Ribai P; Szymanski S; Infante J; van de Warrenburg BP; Dürr A; Timmann D; Boesch S; Fancellu R; Rola R; Depondt C; Schöls L; Zdzienicka E; Kang JS; Ratzka S; Kremer B; Stephenson DA; Melegh B; Pandolfo M; Tezenas du Montcel S; Borkert J; Schulz JB; Klockgether T
    Cerebellum; 2012 Mar; 11(1):155-66. PubMed ID: 21701895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The electrophysiology of spinocerebellar ataxias.
    Liang L; Chen T; Wu Y
    Neurophysiol Clin; 2016 Feb; 46(1):27-34. PubMed ID: 26947625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-motor symptoms in patients with autosomal dominant spinocerebellar ataxia.
    Mastammanavar VS; Kamble N; Yadav R; M N; Jain S; Kumar K; Pal PK
    Acta Neurol Scand; 2020 Oct; 142(4):368-376. PubMed ID: 32677041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.